Founded
Address
Cambridge Cancer Genomics
Cambridge
United Kingdom
Email
Website
Sector
KANDO id: 1051088
Corporate information
Official name
Cambridge Cancer Genomics Ltd
Also known as
CCG
Registration country
Official identities
UK Companies House 10583580
Company type
CCG.ai empowers clinicians to make personalised treatment strategies.Overview
CCG.ai exist to ensure that each patient has the right drug, at the right time, to beat their cancer. We build the software to enable data-driven precision oncology and systematically develop data-driven biomarkers indicative of treatment response. We believe that increasing amounts of clinical and genomic data have the potential to transform cancer treatment, and enable oncologists to make smarter decisions about which drug to use in which circumstance.
Funding rounds
Seed
( )
| Investor | Profile | Country | Notes | |
|---|---|---|---|---|
|
Y Combinator | American technology startup accelerator. | Initial investment. Led the round. |
Investment activity status
Not investing
Team
| Employee | Position | ||
|---|---|---|---|
| John Cassidy (founder) | |||
| Harry Clifford (founder) | |||
| Nirmesh Patel (founder) | |||
| Evaline Tsai (founder) |